Rakshit Drugs Private Limited loan details
Charges taken from banks & financial institutesData last updated:
Amount in (₹)
Rakshit Drugs Private Limited has 7 charges registered with the Registrar of Companies: 1 open charge worth Rs 60.73 Cr and 6 satisfied charges worth Rs 20.29 Cr. The most recent charge was created on 28 Mar 2017 in favour of Sidbi for Rs 9.00 M and is closed.
Charges Breakdown by Lending Institutions
- Others : 60.73 Cr
₹60.73 crore
₹20.29 crore
7
Others
Modification
25 Jul 2025
₹60.73 cr
| Charge Id | Lender | Amount | Creation Date | Last Modification Date | Satisfaction Date | Status |
|---|---|---|---|---|---|---|
| 100086867 View Details | Sidbi | ₹ 0.90 | 28 Mar 2017 | - | 21 Jan 2021 | Satisfied |
| 10115305 View Details | Hdfc Bank Limited | ₹ 0.09 | 24 Jul 2008 | - | 06 Feb 2020 | Satisfied |
| 10168794 View Details | Amneal Pharmaceuticals Company (India) Private Limited | ₹ 13.00 | 12 Jun 2009 | - | 29 Jul 2010 | Satisfied |
| 80001893 View Details | Lakshmi Vilas Bank Limited | ₹ 6.04 | 26 Apr 2002 | 02 Feb 2008 | 10 May 2008 | Satisfied |
| 90262149 View Details | The Lakshmi Vilas Bank Ltd. | ₹ 0.10 | 09 Apr 2002 | 26 Apr 2003 | 10 May 2008 | Satisfied |
| 90261929 View Details | Ap State Financial Corporation | ₹ 0.16 | 16 Jun 2000 | - | 02 May 2002 | Satisfied |
| 10089028 View Details | Others | ₹ 60.73 | 01 Feb 2008 | 25 Jul 2025 | - | Open |
Premium access Charge documents and asset detailsThe filed charge documents and the assets pledged under each charge are in the company report.
Verified entity values are shown only after access is granted. | ||||||
A charge is a security interest a company creates over its assets in favour of a lender. An open charge is still outstanding; a satisfied charge has been repaid and closed with the Registrar. Under the Companies Act, 2013 every charge must be registered within thirty days of creation (Form CHG-1, or CHG-9 for debentures) and its satisfaction reported within thirty days of repayment (Form CHG-4). Amounts are as filed with the MCA.